Bendamustine plus rituximab in newly-diagnosed Waldenstrom macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO)

Affiliation auteurs!!!! Error affiliation !!!!
TitreBendamustine plus rituximab in newly-diagnosed Waldenstrom macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO)
Type de publicationJournal Article
Year of Publication2019
AuteursLaribi K, Poulain S, Willems L, Merabet F, Le Calloch R, Eveillard JR, Herbaux C, Roos-Weil D, Chaoui D, Roussel X, Tricot S, Dupuis J, Dartigeas C, Bareau B, Bene MC, de Materre ABaugier, Leblond V
JournalBRITISH JOURNAL OF HAEMATOLOGY
Volume186
Pagination146-149
Date PublishedJUL
Type of ArticleLetter
ISSN0007-1048
Mots-clésbendamustine, Rituximab, Waldenstrom macroglobulinaemia
DOI10.1111/bjh.15718